CD Biosynsis offers comprehensive Vibrio natriegens Genome Editing Services, utilizing a full suite of precision tools to modify this ultra-fast-growing microbial host for industrial biomanufacturing. V. natriegens is the fastest non-pathogenic organism available, with a doubling time of approximately 10 min, allowing for unprecedented speed in the engineering cycle. Our services provide access to advanced CRISPR-based technologies, including CRISPR-Cas9 for large-scale integration and deletion, Base Editing for single-nucleotide precision, and CRISPRi for tunable gene repression. We specialize in overcoming the unique challenges of V. natriegens's dual-chromosome genome, ensuring highly efficient and stable modifications that accelerate metabolic pathway optimization, host engineering for tolerance, and rapid production of high-value compounds.
Get a QuoteEffective metabolic engineering in V. natriegens requires precise control over gene function—from complete elimination to subtle tuning. Our integrated Genome Editing platform provides all necessary tools to achieve these goals: robust gene deletion for eliminating competing pathways, accurate knock-in for pathway installation, and fine-tuning tools for balancing expression. The ability to rapidly implement and verify these edits, thanks to the host's rapid growth, is the core value we deliver, dramatically shortening the path to commercial readiness.
Standard editing platform for targeted DNA double-strand breaks (DSBs), used for introducing large insertions, deletions, and general genome restructuring.
DSB-free system for highly efficient, clean single-nucleotide substitutions (C>T or A>G), perfect for promoter/RBS tuning and point mutation introduction.
Tunable and reversible gene knockdown (repression) for rapidly optimizing the expression balance of essential genes or native competing pathways.
Permanent, markerless deletion of one or multiple genes to eliminate undesirable byproduct formation or remove competing metabolic pathways.
Accurate insertion of large DNA fragments, such as synthetic operons or full biosynthetic pathways, into safe harbor sites on the genome.
Promoter and RBS Tuning
Precise engineering of regulatory elements to control the timing and strength of gene expression, crucial for high-flux metabolism.
Metabolic Pathway Installation
Integration and optimization of heterologous genes into the dual-chromosome genome to enable the production of novel high-value compounds.
Improved Stress Tolerance
Engineering the host to withstand high concentrations of products, salts, or inhibitors commonly encountered in industrial fermentation environments.
Feedstock Flexibility
Modification of native genes or insertion of foreign genes to enable efficient utilization of diverse, low-cost carbon sources (e.g., glycerol, sugar mixtures).
A systematic process for rational design, precise editing, and verification.
1. Rational Design & Strategy
2. Tool Construction & Delivery
3. High-Throughput Screening
4. Verification & Stabilization
Identify all necessary genomic modifications (KO, KI, tuning) using metabolic modeling or predictive analysis.
Design appropriate gRNAs, repair templates, and regulatory sequences.
Select the most suitable editing tool (Cas9, BE, or CRISPRi) based on the modification type.
Construct the editing tool expression system and necessary DNA parts.
Introduce the editing components into the V. natriegens host via optimized transformation/conjugation protocols.
Transiently induce the editing machinery to minimize host stress.
Final confirmation of the clean, markerless genomic edit across all target loci.
If applicable, integrate the final pathway into a stable chromosomal site.
Delivery of the verified V. natriegens strain and comprehensive editing report.
Accelerated Editing Cycle
The host's 10-minute doubling time allows for rapid clone recovery and propagation, compressing the time needed for multiple iterative edits and verification steps.
Full Toolset Coverage
We provide all necessary editing modalities (KO, KI, Repression, Base Editing), allowing us to choose the most efficient and precise tool for any genomic target.
Dual-Chromosome Mastery
Specialized protocols ensure successful editing and stable integration across both Chromosome I and Chromosome II, managing the unique challenges of the V. natriegens genome.
Markerless and Stable
All permanent modifications are performed markerlessly and integrated into the chromosome, guaranteeing strain stability and suitability for industrial scale-up without antibiotic pressure.
1. Why is V. natriegens considered the ideal host for rapid genome editing?
Its extremely fast growth rate (approximately 10 min doubling time) significantly accelerates the entire editing workflow, including plasmid curing, clone recovery, and verification steps, dramatically shortening project timelines.
2. Can you perform multiple simultaneous genomic modifications?
Yes. We use multiplexed CRISPR systems to introduce several edits (knockouts or knock-ins) in a single step. The specific strategy (simultaneous or sequential) is determined by the target genes' potential toxicity.
3. What is the difference between Base Editing and CRISPR-Cas9 for gene editing?
CRISPR-Cas9 creates a double-strand break (DSB) for large insertions or deletions. Base Editing is DSB-free, performing only clean single-nucleotide conversions (point mutations), offering higher precision and less off-target risk for fine-tuning.
4. How do you address the unique challenge of the V. natriegens dual-chromosome genome?
Our editing systems and gRNA designs are specifically optimized to function robustly across both Chromosome I and II, ensuring successful and stable integration or deletion regardless of the gene's location.
5. Is the final engineered strain free of foreign DNA (markerless)?
Yes. For all permanent modifications (KO, KI), we employ markerless techniques to ensure the final delivered strain contains only the desired genomic change, without residual antibiotic resistance genes or plasmid components.
6. How is the success of a modification verified?
Verification is done via genotype confirmation (Sanger sequencing, junction PCR, or dPCR) and phenotype analysis (measuring growth rate, product titer, or stress tolerance) to ensure the edit is both precise and functional.
7. Can you integrate entire biosynthetic pathways (operons) into the genome?
Yes. We use CRISPR-Cas9 to perform targeted gene knock-ins of large DNA cassettes (up to 10 kb or more), enabling the stable integration of entire biosynthetic operons into safe harbor sites.
8. What input information is required for a genome editing project?
We require the V. natriegens host strain (or wild-type) and the precise coordinates or details of the desired modification (e.g., gene name for knockout, or target sequence and insertion fragment for knock-in).
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.